Homo-and hetero-dimeric complex formations of the human oxytocin receptor

Journal of Neuroendocrinology

Volumn 16, Issue 4, 2004, Pages 372-377

  Devost, D ^a   Zingg, Hans H ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Bioluminescence resonance energy transfer (BRET); Oxytocin receptor; Receptor dimerization and oligomerization

Indexed keywords

BRADYKININ RECEPTOR; G PROTEIN COUPLED RECEPTOR; LIGAND; OLIGOMER; OXYTOCIN; OXYTOCIN RECEPTOR; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN V2 RECEPTOR;

ANIMAL CELL; ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CELL SURFACE; COMPLEX FORMATION; CONTROLLED STUDY; IMMUNOPRECIPITATION; IN VIVO STUDY; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN FAMILY; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION;

DIMERIZATION; HUMANS; RECEPTORS, OXYTOCIN; SIGNAL TRANSDUCTION;

EID: 2442438851     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0953-8194.2004.01188.x     Document Type: Article

References (28)

1. Eidne KA. Application of novel resonance energy transfer techniques to study dynamic hormone receptor interactions in living cells. Trends Endocrinol Metab 2002; 13: 415-421.
2. Angers S, Salahpour A, Bouvier M. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol 2002; 42: 409-435.
3. Salahpour A, Angers S, Bouvier M. Functional significance of oligomerization of G-protein-coupled receptors. Trends Endocrinol Metab 2000; 11: 163-168.
4. Patel RC, Kumar U, Lamb DC, Eid JS, Rocheville M, Grant M, Rani A, Hazlett T, Patel SC, Gratton E, Patel YC. Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells. Proc Natl Acad Sci USA 2002; 99: 3294-3299.
5. Latif R, Graves P, Davies TF. Ligand-dependent inhibition of oligomerization at the human thyrotropin receptor. J Biol Chem 2002; 277: 45059-45067.
6. Issafras H, Angers S, Bulenger S. Blanpain C, Parmentier M, Labbe-Jullie C, Bouvier M, Marullo S. Constitutive agonist-independent CCR5 oligomerization and antibody-mediated clustering occurring at physiological levels of receptors. J Biol Chem 2002; 27: 27.
7. Zingg HH. Vasopressin and oxytocin receptors. Balliere's Clin Endocrinol Metab 1996; 10: 75 96.
8. Ku CY, Qian A, Wen Y, Anwer K, Sanborn BM. Oxytocin stimulates myometrial guanosine triphosphatase and phospholipase-C activities via coupling to G alpha q/11. Endocrinology 1995; 136: 1509-1515.
9. Strakova Z, Soloff MS. Coupling of oxytocin receptor to G proteins in rat myometrium during labor: Gi receptor interaction. Am J Physiol 1997; 272: E870-E876.
10. Zingg HH, Laporte SA. The oxytocin receptor. Trends Endocrinol Metab 206: 14: 222 227.
11. Breton C, Chellil H, Kabbaj-Benmansour M, Carnazzi E, Seyer R, Phalipou S, Morin D, Durroux T, Zingg H, Barberis C, Mouillac B. Direct identification of human oxytocin receptor-binding domains using a photoactivatable cyclic peptide antagonist: comparison with the human V1a vasopressin receptor. J Biol Chem 2001; 276: 26931-26941.
12. Fanelli F, Barbier P, Zanchetta D, de Benedetti PG, Chini B. Activation mechanism of human oxytocin receptor: a combined study of experimental and computer-simulated mutagenesis. Mol Pharmacol 1999; 56: 214 225.
13. Hawfin SR, Howard HC, Wheatley M. Identification of an extracellular segment of the oxytocin receptor providing agonist-specific binding epitopes. Biochem J 2001; 354: 465-472.
14. Postina R, Kojro E, Fahrenholz F. Separate agonist and peptide antagonist binding sites of the oxytocin receptor defined by their transfer into the V2 vasopressin receptor. J Biol Chem 1996; 271: 31593-31601.
15. Fuchs A-R, Helmer H, Behrens O, Liu H-C, Antonian L, Chang S, Fields M. Oxytocin and bovine parturition: a steep rise in endometrial oxytocin receptors precedes onset of labor. Biol Reprod 1992; 47: 937-944.
16. Devost D, Zingg HH. Identification of dimeric and oligomeric complexes of the human oxytocin receptor by co-immunoprecipitation and bioluminescence resonance energy transfer. J Mol Endocrinol 2003; 31: 461-471.
17. Zeng FY, Wess J. Identification and molecular characterization of m3 muscarinic receptor dimers. J Biol Chem 1999; 274: 19487-19497.
18. Cvejic S, Devi LA. Dimerization of the delta opioid receptor: implication for a role in receptor internalization. J Biol Chem 1997; 272: 26959-26964.
19. Ayoub MA, Couturier C, Lucas-Meunier E, Angers S, Fossier P, Bouvier M, Jockers R. Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer. J Biol Chem 2002; 277: 21522-21528.
20. Xu Y, Piston DW, Johnson CH. A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins. Proc Natl Acad Sci USA 1999; 96: 151-156.
21. Angers S, Salahpour A, Joly E, Hilairet S, Chelsky D, Dennis M, Bouvier M. Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci USA 2000; 97: 3684-3689.
22. Terrillon S, Durroux T, Mouillac B, Breit A, Ayoub M, Taulan M, Jockers R, Barberis C, Bouvier M. Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. Mol Endocrinol 2003; 17: 677-691.
23. Hebert TE, Moffett S, Morello J-P, Loisel TP, Bichet DG, Barret C, Bouvier M. A peptide derived from a beta 2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem 1996; 271: 16384-16392.
24. Schoneberg T, Yun J, Wenkert D, Wess J. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a coexpressed receptor polypeptide. EMBO J 1996; 15: 1283-1291.
25. Schoneberg T, Sandig V, Wess J, Gudermann T, Schultz G. Reconstitution of mutant V2 vasopressin receptors by adenovirus-mediated gene transfer. Molecular basis and clinical implication. J Clin Invest 1997; 100: 1547-1556.
26. Schulz A, Grosse R, Schultz G, Gudermann T, Schoneberg T. Structural implication for receptor oligomerization from functional reconstitution studies of mutant V2 vasopressin receptors. J Biol Chem 2000; 275: 2381-2389.
27. Zhu X, Wess J. Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function. Biochemistry 1998; 37: 15773-15784.
28. Chen DC, Chan WY, Manning M. Agonist and antagonist specificities of decidual prostaglandin-releasing and myometrial uterotonic oxytocin receptors in pregnant rats. J Reprod Fertil 1994; 102: 337-343.